← Back to Clinical Trials
Recruiting NCT07045623

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Hypertension
Sponsor Saint Vincent's Hospital, Korea
Study Type INTERVENTIONAL
Phase N/A
Enrollment 348
Sex ALL
Min Age 30 Years
Max Age 80 Years
Start Date 2025-04-01
Completion 2025-12-31
Interventions
centralized management and education group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.

Eligibility Criteria

Inclusion Criteria: * Patients registered in the Hanam City Hypertension and Diabetes Program * Adults aged 30 to 80 years * Individuals who have provided written informed consent to participate in the study Exclusion Criteria: * Chronic kidney disease stage 4 or higher (eGFR \<30 mL/min/1.73m²) * Patients with liver cirrhosis or severe liver disease * Patients with a history of acute coronary syndrome within the past 6 months * Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}